Su-Yu Zhu

机构：Hunan Cancer Hospital

发表论文 11 篇 · 总被引 677 次 · h-index 10

代表论文

• Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study (2015 · Blood · 被引 184)
• Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making (2020 · Leukemia · 被引 133)
• Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma (2016 · JAMA Oncology · 被引 85)
• First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG (2020 · Blood Advances · 被引 60)
• Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) (2018 · Radiotherapy and Oncology · 被引 49)
• Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma (2019 · JAMA Network Open · 被引 48)